Inhibition of T Lymphocyte Activation by cAMP Is Associated with Down-Regulation of Two Parallel Mitogen-Activated Protein Kinase Pathways, the Extracellular Signal-Related Kinase and c-Jun N-Terminal Kinase

Journal of Immunology

Volumn 157, Issue 4, 1996, Pages 1514-1522

  Tamir, Ami ^a   Granot, Yosef ^a   Isakov, Noah ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BISINDOLYLMALEIMIDE I; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FORSKOLIN; INDOLE DERIVATIVE; ISOENZYME; MALEIMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; NERVE PROTEIN; OKT 3; ONCOPROTEIN; PEPTIDE FRAGMENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN KINASE LCK; STRESS ACTIVATED PROTEIN KINASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; BUCLADESINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; FORSKOLIN; HUMANS; INDOLES; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA, T-CELL; MALEIMIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; MOLECULAR SEQUENCE DATA; MUROMONAB-CD3; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0030586676     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
2. Mustelin, T., K. M. Coggeshall, N. Isakov, and A. Altman. 1990. T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science 247:265.
3. Isakov, N., R. L. Wange, and L. E. Saraelson. 1994. The role of tyrosine kinases and phosphotyrosine-containing recognition motifs in regulation of the T cell-antigen receptor-mediated signal transduction pathway. J. Leukocyte Biol. 55: 265.
4. Isakov, N., W. Scholz, M. Mally, and A. Altman. 1987. T lymphocyte activation: the role of protein kinase C and the bifurcating signal transduction pathway. Immunol. Rev. 95:89.
5. ras regulatory pathways coexist in T cells. Mol. Cell. Biol. 12:3305.
6. ras mediates control of IL-2 gene promoter function in T cell activation. EMBO J. 11:4549.
7. Izquierdo, M., S. Bowden, and D. A. Cantrell. 1994. The role of Raf-1 in the regulation of extracellular signal-regulated kinase 2 by the T cell antigen receptor. J. Exp. Med. 180:401.
8. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-Jun mediated by MAP kinases. Nature 353:670.
9. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein ELK-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381.
10. lck at serine-59. J. Immunol. 151:6862.
11. Izquierdo, M., S. L. Leevers, D. H. Williams, C. J. Marshall, A. Weiss, and D. A. Cantrell. 1994. The role of protein kinase C in the regulation of extracellular signal-regulated kinase by the T cell antigen receptor. Eur. J. Immunol. 24:2462.
12. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135.
13. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neria. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727.
14. Gupta, S., D. Campbell, B. Derijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389.
15. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Dérijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719.
16. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Ruble, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase sub-family of c-Jun kinases. Nature 369:156.
17. Dérijard, B., M. Hibi, L-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025.
18. Henney, C. S., L. M. Lichtenstein, E. Gillespie, and R. T. Rolley. 1973. In vivo suppression of the immune response to alloantigen by cholera enterotoxin. J. Clin. Invest. 52:2853.
19. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferring receptor expression. J. Immunol. 135:1172.
20. Goodwin, J. S., A. D. Bankhurst, and R. P. Messner. 1977. Suppression of human T-cell mitogenesis by prostaglandin: existence of a prostaglandin- producing suppressor cell. J. Exp. Med 146:1719.
21. Gilbert, K. M., and M. K. Hoffmann. 1985. cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells. J. Immunol 135:2084.
22. Alava, M. A., K. E. DeBell, A. Conti, T. Hoffman, and E. Bonvini. 1992. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation: association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1. Biochem. J. 284:189.
23. Granja, C., L.-L. Lin, E. J. Yunis, V. Relias, and J. D. Dasgupta. 1991. PLCγ1, a possible mediator of T cell receptor function. J. Biol. Chem. 266:16277.
24. Lerner, A., B. Jacobson, and R. Miller. 1988. Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse T lymphocytes. J. Immunol. 140:936.
25. Bismuth, G., I. Theodorou, H. Gouy, S. Le Gouvello, A. Bernard, and P. Debre. 1988. Cyclic AMP-mediated alteration of the CD2 activation process in human T lymphocytes: preferential inhibition of the phosphoinositide cycle-related transduction pathway. Eur. J. Immunol. 18:1351.
26. Patel, M. D., L. E. Samelson, and R. D. Klausner. 1987. Multiple kinases and signal transduction: phosphorylation of the T cell antigen receptor complex. J. Biol. Chem. 262:5831.
27. Klausner, R. D., J. J. O'Shea, H. Luong, P. Ross, J. A. Bluestone, and L. E. Samelson. 1987. T cell receptor tyrosine phosphorylation, variable coupling for different ligands. J. Biol. Chem. 262:12654.
28. Tamir, A., and N. Isakov. 1994. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes: evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J. Immunol. 152:3391.
29. Chen, D., and E. V. Rothenberg. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931.
30. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148:2845.
31. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065.
32. Laxminarayana, D., A. Berrada, and G. M. Kammer. 1993. Early events of human T lymphocyte activation are associated with type I protein kinse A activity. J. Clin. Invest. 92:2207.
33. Laxminarayana, D., and G. M. Kammer. 1996. Activation of type 1 protein kiase A during receptor-mediated human T lymphocyte activation. J. Immunol. 156: 497.
34. SkŚlhegg, B. S., K. Taskén, V. Hansson, H. S. Huitfeldt, T. Jahnsen, and T. Lea. 1994. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science 263:84.
35. SkŚlhegg, B. S., B. F. Landmark, S. O. Døskeland, V. Hansson, T. Lea, and T. Jahnsen. 1992. Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′, 5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267:15707.
36. SkŚlhegg, B. S., A. M. Rasmussen, K. Tasken, V. Hansson, T. Jahnsen, and T. Lea. 1994. Cyclic AMP-sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex. Scand. J. Immunol. 40:201.
37. Countaway, J. L., I. C. Northwood, and R. J. Davis. 1989. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 264:10828.
38. Aviv, H., and P. Leder. 1972. Purification of biologically active globin mRNA by chromatography on oligothymidil acid-cellulose. Proc. Natl. Acad. Sci. USA 69: 1408.
39. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
40. Northwood, I. C., F. A. Gonzalez, M. Wartmann, D. L. Raden, and R. J. Davis. 1991. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 266:15266.
41. Kameshita, I., and H. Fujisawa. 1989. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem. 183:139.
42. 2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation. Cell. Immunol. 158:195.
43. Cooper, J. A., B. M. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 99:387.
44. Isakov, N. 1993. Tyrosine phosphorylation and dephosphorylation in T lympho-cyte activation. Mol. Immunol. 30:197.
45. Rudd, C. E., J. M. Trevillyan, J. D. Dasgupta, L. L. Wong, and S. F. Schlossman. 1988. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc. Natl. Acad. Sci. USA 85:5190.
46. lck. Cell 55:301.
47. Casnellie, J. E., M. L. Harrison, K. E. Hellstrom, and E. G. Krebs. 1983. A lymphoma cell line expressing elevated levels of tyrosine protein kinase activity. J. Biol. Chem. 258:10738.
48. Luo, K. X., and B. M. Sefton. 1990. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the Lck tyrosine protein kinase at the autophosphorylation site. Mol. Cell. Biol. 10:5305.
49. lck. Proc. Natl. Acad. Sci. USA 90:5176.
50. Casnellie, J. E., and R. J. Lamberts. 1986. Tumor promoters cause changes in the state of phosphorylation and apparent molecular weight of a tyrosine protein kinase in T lymphocytes. J. Biol. Chem. 26:4921.
51. lck) during T-cell activation. Mol. Cell. Biol. 8:4353.
52. lck). J. Immunol. 142:2430.
53. lck. J. Biol. Chem. 268:27420.
54. Ahn, N. G., R. Seger, and E. G. Krebs. 1992. The mitogen-activated protein kinase activator. Curr. Opin. Cell. Biol. 4:992.
55. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
56. Isakov, N., D. Galron, T. Mustelin, G. R. Pettit, and A. Altman. 1993. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J. Immunol. 150:1195.
57. Tamir, A., and N. Isakov. 1991. Increased intracellular cyclic AMP levels block PKC-mediated T cell activation by inhibition of c-jun transcription. Immunol. Lett. 27:95.
58. Carroll, M. P., J. L. Spivak, M. McMahon, N. Weich, U. R. Rapp, and W. S. May. 1991. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Sci. 266:14964.
59. Carroll, M. P., and W. S. May. 1994. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J. Biol. Chem. 269:1249.
60. Riedel, D., U. Brennscheidt, M. Kiehntopf, M. Brach, and F. Hermann. 1993. The mitogenic response of T cells to interleukin-2 requires Raf-1. Eur. J. Immunol. 23:3146.
61. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marmé, and U. R. Rapp. 1993. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 364:249.
62. Siegel, J. N., R. D. Klausner, U. R. Rapp, and L. E. Samelson. 1990. T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway. J. Biol. Chem. 265:18472.
63. Harwood, A. E., and J. H. Cambier. 1993. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras. J. Immunol. 151:4513.
64. Avruch, J., X. Zhang, and J. M. Kyriakis. 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19:279.
65. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activaled MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065.
66. Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069.
67. Loh, C., C. Romeo, B. Seed, J. T. Bruder, U. Rapp, and A. Rao. 1994. Association of Raf with the CD3 δ and γ chains of the T cell receptor-CD3 complex. J. Biol. Chem. 269:8817.
68. Cano, E., and L. C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117.
69. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326.
70. ras. Mol. Cell. Biol. 14:6944.
71. Vaillancourt, R. R., A. M. Gardner, and G. L. Johnson. 1994. B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol. Cell. Biol. 14:6522.
72. Bartik, M. M., G. P. Bauman, W. H. Brooks, and T. L. Roszman. 1994. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell. Immunol. 158:116.
73. Isakov, N., R. C. Bleackley, J. Shaw, and A. Altman. 1985. The tumor promoter teleocidin induces IL-2 receptor expression and IL-2-independent proliferation of human peripheral blood T cells. J. Immunol. 135:2343.
74. Isakov, N., R. C. Bleackley, J. Shaw, and A. Altman. 1985. Teleocidin and phorbol ester tumor promoters exert similar mitogenic effects on human lymphocytes. Biochem. Biophys. Res. Commun. 130:724.
75. Ward, Y., S. Gupta, P. Jensen, M. Wartmann, R. J. Davis, and K. Kelly. 1994. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367:651.